In just five years, Enaleni Pharmaceuticals has firmly positioned itself as a top ten South African pharmaceutical company. Listed on the Johannesburg Securities Exchange (JSE), the group comprises two divisions, namely
Cipla Medpro, itself the 6th largest local pharmaceutical company and one of SA’s leading suppliers of chronic and generic medicines; and the Enaleni Pharma Contract Manufacturing division (soon to be renamed Cipla Medpro Manufacturing), a 4 000 m
2 manufacturing facility which, as a result of a current R125 million upgrade, will shortly be one of the first internationally PIC/S compliant facilities in South Africa.
read more
